Home / Drugs / ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexent

ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexent

FDA Drug Profile — PNV-DHA

Drug Details

Generic Name: ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexent
Brand Names: PNV-DHA
Application Number
Sponsor: Acella Pharmaceuticals, LLC
NDC Codes: 1
Dosage Forms: CAPSULE, GELATIN COATED
Routes: ORAL
Active Ingredients: .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CALCIUM, CHOLECALCIFEROL, DOCONEXENT, FERROUS FUMARATE, FOLIC ACID, PYRIDOXINE

Indications and Usage

INDICATIONS PNV-DHA + Docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

Warnings

WARNING Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.